VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 49 filers reported holding VOR BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46 | -30.3% | 21,616 | +2.0% | 0.00% | – |
| Q2 2023 | $66 | -93.4% | 21,200 | +11057.9% | 0.00% | – |
| Q2 2022 | $1,000 | -98.5% | 190 | -98.2% | 0.00% | – |
| Q1 2022 | $65,000 | -47.6% | 10,694 | +0.4% | 0.00% | – |
| Q4 2021 | $124,000 | +1.6% | 10,649 | +36.4% | 0.00% | – |
| Q3 2021 | $122,000 | -42.2% | 7,806 | -30.9% | 0.00% | – |
| Q2 2021 | $211,000 | -43.1% | 11,292 | +31.3% | 0.00% | – |
| Q1 2021 | $371,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |